Business Context and Reporting Period
This Form 6-K filing by Akari Therapeutics Plc covers the month of August 2017. The report discloses an amendment to the executive employment agreement of Robert Shaw, the Company's General Counsel and Company Secretary, effective August 2, 2017.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation and employment terms rather than financial performance.
Material Changes
The primary material change is the execution of Amendment No. 2 to Mr. Shaw's employment agreement, which includes:
- Expanded Responsibilities: Mr. Shaw will serve as Chief Compliance Officer (CCO) and head of governance, intellectual property (IP), and information technology (IT) functions, in addition to his existing roles as Chief Legal Officer (CLO) and Company Secretary.
- Reporting Structure: He will report to the Executive Chairman regarding Company Secretary, CCO, and governance duties, and to the Chief Executive Officer regarding CLO, IP, and IT duties.
- Compensation Increase: Base salary increased to $318,000. The target annual performance bonus increased to 40% of base salary.
- Termination Benefits: In the event of termination without cause, for good reason, or upon non-renewal, Mr. Shaw is entitled to 12 months of base salary, the greater of actual or target annual performance bonus, and 12 months of the Company's share of medical insurance premiums.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on business strategy, or specific risk factors beyond the standard incorporation of the employment amendment by reference.
Investor Verification Checklist
- Verify the total annualized cost of the amended compensation package for Robert Shaw.
- Review the full text of Exhibit 10.1 for any additional covenants or restrictions not summarized in the filing.
- Assess the impact of the expanded IP and IT oversight responsibilities on the Company's operational structure.
- Confirm if similar compensation adjustments are planned for other executive officers.